Aesthetics products maker Allergan (NYSE:AGN) last night adopted a "poison pill" strategy designed to insulate the company from a surprise $47 billion hostile takeover.
Mergers & Acquisitions
Medline nabs Amendia’s cervical spinal surgery tech in closed-doors deal
Illinois-based Medline Industries acquired key spine surgery technologies from Georgia-based Amendia, the companies announced this month.
Medline nabbed Amendia’s anterior cervical fusion distraction pin business, part of a market that Medline expects to grow more than 8% annually. The technologies are used in surgeries for removing problem disks in the neck area of the spine.
Embattled ConMed surges on reports of potential sale
Stryker closes $172M acquisition of Berchtold Holding
Report: Covidien pays $100M for New Wave Surgical
Smith & Nephew pays $12M to settle stockholder lawsuit ahead of ArthroCare buyout
Varian closes stealthy acquisition of Velocity cancer-management software
California device maker Varian Medical (NYSE:VAR) remained tight-lipped about its bid for software maker Velocity Medical Solutions as it announced the acquisition’s close today.
Cardinal Health nabs AccessClosure for $320M
Ohio-based Cardinal Health (NYSE:CAH) made a $320 million all-cash bid to acquire AccessClosure and its extravascular closure technology.